Robust agreement between AI and expert assessment of LV volume and ejection fraction in contrast echo
Apr 30, 2024
Us2.ai automatically generates clinically relevant and reproducible quantitative echocardiographic left ventricular (LV) measurements, eliminating human intra-operator variability and reducing analysis time, as reported in Nature Communications.
A study presented at ACC.24 aimed to assess the effectiveness of Us2.ai when utilizing ultrasound enhancing agents. The results indicated a strong agreement between human interpretations and AI, validating the potential of AI for contrast echo. This expands the range of AI capabilities and benefits within clinical workflows.